The Evaluation Value of the Modified Lund-Kennedy Nasal Endoscopy Score on the Efficacy of Sublingual Immunotherapy for Allergic Rhinitis.

IF 2.5 3区 医学 Q1 OTORHINOLARYNGOLOGY
American Journal of Rhinology & Allergy Pub Date : 2024-11-01 Epub Date: 2024-08-16 DOI:10.1177/19458924241269786
Yinglong Zhang, Hong Jiang, Yu Long, Jie Li
{"title":"The Evaluation Value of the Modified Lund-Kennedy Nasal Endoscopy Score on the Efficacy of Sublingual Immunotherapy for Allergic Rhinitis.","authors":"Yinglong Zhang, Hong Jiang, Yu Long, Jie Li","doi":"10.1177/19458924241269786","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Allergic rhinitis (AR) is a growing public health problem worldwide. Respecting the significance of the modified Lund-Kennedy (MLK) score in rhinitis assessment, we delved into its evaluation value on the sublingual immunotherapy (SLIT) efficacy in AR patients.</p><p><strong>Methods: </strong>Totally 100 AR patients were enrolled, with pre- and post-SLIT MLK score, total nasal symptoms score (TNSS), total medication score (TMS), visual analogue scale (VAS), inflammatory cytokines, and immune function-related parameters compared. The correlations of MLK score with TNSS/TMS/VAS, as well as with IL-4/INF-γ/eosinophil (EOS)/percentage/specific immunoglobulin (sIgE)/sIgG were assessed by Spearman correlation analysis. The value of MLK score on assessing SLIT efficacy in AR patients was analyzed.</p><p><strong>Results: </strong>SLIT treatment reduced MLK/TNSS/TMS/VAS scores, abated IL-4 level/EOS percentage/sIgE, and elevated INF-γ/sIgG levels. MLK score was positively correlated with pre- and post-SLIT TNSS score (r<sub>pre-treatment </sub>= 0.592, r<sub>post-treatment </sub>= 0.756), TMS score (r<sub>pre-treatment </sub>= 0.385, r<sub>post-treatment </sub>= 0.718), VAS score (r<sub>pre-treatment </sub>= 0.369, r<sub>post-treatment </sub>= 0.704), IL-4 (r<sub>pre-treatment </sub>= 0.553, r<sub>post-treatment </sub>= 0.639), EOS percentage (r<sub>pre-treatment </sub>= 0.511, r<sub>post-treatment </sub>= 0.632), and sIgE (r<sub>pre-treatment </sub>= 0.472, r<sub>post-treatment </sub>= 0.524), and negatively with INF-γ (r<sub>pre-treatment </sub>= -0.418, r<sub>post-treatment </sub>= -0.578) and sIgG4 (r<sub>pre-treatment </sub>= -0.460, r<sub>post-treatment </sub>= -0.613). The MLK score had an area under curve of 0.846 (77.01% sensitivity, 76.92% specificity, 4 cut-off value) and 0.944 (91.67% sensitivity, 92.11% specificity, 2 cut-off value) for assessing SLIT treatment as effective and markedly effective for the patients, respectively.</p><p><strong>Conclusion: </strong>The MLK score had good evaluation value on the efficacy of SLIT treatment in AR patients.</p>","PeriodicalId":7650,"journal":{"name":"American Journal of Rhinology & Allergy","volume":" ","pages":"366-372"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Rhinology & Allergy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/19458924241269786","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Allergic rhinitis (AR) is a growing public health problem worldwide. Respecting the significance of the modified Lund-Kennedy (MLK) score in rhinitis assessment, we delved into its evaluation value on the sublingual immunotherapy (SLIT) efficacy in AR patients.

Methods: Totally 100 AR patients were enrolled, with pre- and post-SLIT MLK score, total nasal symptoms score (TNSS), total medication score (TMS), visual analogue scale (VAS), inflammatory cytokines, and immune function-related parameters compared. The correlations of MLK score with TNSS/TMS/VAS, as well as with IL-4/INF-γ/eosinophil (EOS)/percentage/specific immunoglobulin (sIgE)/sIgG were assessed by Spearman correlation analysis. The value of MLK score on assessing SLIT efficacy in AR patients was analyzed.

Results: SLIT treatment reduced MLK/TNSS/TMS/VAS scores, abated IL-4 level/EOS percentage/sIgE, and elevated INF-γ/sIgG levels. MLK score was positively correlated with pre- and post-SLIT TNSS score (rpre-treatment = 0.592, rpost-treatment = 0.756), TMS score (rpre-treatment = 0.385, rpost-treatment = 0.718), VAS score (rpre-treatment = 0.369, rpost-treatment = 0.704), IL-4 (rpre-treatment = 0.553, rpost-treatment = 0.639), EOS percentage (rpre-treatment = 0.511, rpost-treatment = 0.632), and sIgE (rpre-treatment = 0.472, rpost-treatment = 0.524), and negatively with INF-γ (rpre-treatment = -0.418, rpost-treatment = -0.578) and sIgG4 (rpre-treatment = -0.460, rpost-treatment = -0.613). The MLK score had an area under curve of 0.846 (77.01% sensitivity, 76.92% specificity, 4 cut-off value) and 0.944 (91.67% sensitivity, 92.11% specificity, 2 cut-off value) for assessing SLIT treatment as effective and markedly effective for the patients, respectively.

Conclusion: The MLK score had good evaluation value on the efficacy of SLIT treatment in AR patients.

改良隆德-肯尼迪鼻内窥镜检查评分对舌下免疫疗法治疗过敏性鼻炎疗效的评估价值
目的:过敏性鼻炎(AR)是全球日益严重的公共卫生问题。鉴于改良隆德-肯尼迪(MLK)评分在鼻炎评估中的重要意义,我们深入研究了其对鼻炎患者舌下免疫疗法(SLIT)疗效的评估价值:方法:共招募了100名AR患者,比较了舌下免疫疗法前后的MLK评分、鼻腔症状总评分(TNSS)、用药总评分(TMS)、视觉模拟量表(VAS)、炎症细胞因子和免疫功能相关参数。通过斯皮尔曼相关分析评估了 MLK 评分与 TNSS/TMS/VAS 以及 IL-4/INF-γ/嗜酸性粒细胞(EOS)/百分比/特异性免疫球蛋白(sIgE)/sIgG 的相关性。分析了MLK评分对评估SLIT在AR患者中疗效的价值:结果:SLIT治疗降低了MLK/TNSS/TMS/VAS评分,缓解了IL-4水平/EOS百分比/sIgE,升高了INF-γ/sIgG水平。MLK 评分与治疗前和治疗后的 TNSS 评分(治疗前 = 0.592,治疗后 = 0.756)、TMS 评分(治疗前 = 0.385,治疗后 = 0.718)、VAS 评分(治疗前 = 0.369,治疗后 = 0.704)、IL-4(治疗前 = 0.553,治疗后 = 0.639)、EOS 百分比(治疗前 = 0.511,治疗后 = 0.632)和 sIgE(治疗前 = 0.472,治疗后 = 0.524),与 INF-γ (治疗前 = -0.418,治疗后 = -0.578)和 sIgG4(治疗前 = -0.460,治疗后 = -0.613)呈负相关。在评估 SLIT 治疗对患者有效和明显有效时,MLK 评分的曲线下面积分别为 0.846(灵敏度为 77.01%,特异度为 76.92%,截断值为 4)和 0.944(灵敏度为 91.67%,特异度为 92.11%,截断值为 2):MLK评分对SLIT治疗AR患者的疗效具有良好的评估价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.60
自引率
11.50%
发文量
82
审稿时长
4-8 weeks
期刊介绍: The American Journal of Rhinology & Allergy is a peer-reviewed, scientific publication committed to expanding knowledge and publishing the best clinical and basic research within the fields of Rhinology & Allergy. Its focus is to publish information which contributes to improved quality of care for patients with nasal and sinus disorders. Its primary readership consists of otolaryngologists, allergists, and plastic surgeons. Published material includes peer-reviewed original research, clinical trials, and review articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信